Global In vitro Micronucleus Test Market Growth (Status and Outlook) 2025-2031

According to this study, the global In vitro Micronucleus Test market size will reach US$ 159 million by 2031.

The in vitro micronucleus test is a cytotoxicity and genotoxicity assay used to detect DNA damage in eukaryotic cells by assessing the formation of micronuclei—small, membrane-bound structures containing fragmented or whole chromosomes that fail to segregate properly during cell division. Conducted in vitro (using cultured cells, such as mammalian cell lines or human peripheral blood lymphocytes), the test involves exposing cells to a test substance (e.g., chemicals, pharmaceuticals, nanoparticles) under both metabolic activation (using S9 liver homogenate to mimic in vivo biotransformation) and non-activation conditions. After incubation, cells are fixed, stained, and analyzed microscopically to quantify micronucleus frequency in interphase or mitotic cells. An increase in micronuclei compared to negative controls indicates potential clastogenic (chromosome-breaking) or aneugenic (chromosome-segregation-disrupting) effects, making this test critical for assessing the genotoxic potential of compounds in regulatory toxicology, drug development, and environmental hazard screening.

United States market for In vitro Micronucleus Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for In vitro Micronucleus Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for In vitro Micronucleus Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key In vitro Micronucleus Test players cover Charles River Laboratories, Intertek, Xenometrix, Evotec, Eurofins, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “In vitro Micronucleus Test Industry Forecast” looks at past sales and reviews total world In vitro Micronucleus Test sales in 2024, providing a comprehensive analysis by region and market sector of projected In vitro Micronucleus Test sales for 2025 through 2031. With In vitro Micronucleus Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In vitro Micronucleus Test industry.

This Insight Report provides a comprehensive analysis of the global In vitro Micronucleus Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In vitro Micronucleus Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In vitro Micronucleus Test market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In vitro Micronucleus Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In vitro Micronucleus Test.

This report presents a comprehensive overview, market shares, and growth opportunities of In vitro Micronucleus Test market by product type, application, key players and key regions and countries.

Segmentation by Type:
Mammalian Cell Lines
Primary Cells
Others

Segmentation by Application:
Pharmaceuticals
Agrochemical/Chemical
Cosmetics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
Intertek
Xenometrix
Evotec
Eurofins
SGS
Nuvisan
Aurigene
QPS Holdings
InVitro Research Solutions
CD Formulation
Wuxi Apptec
Xishan Zhongke
Pharmaron
WestChina-Frontier PharmaTech Co., Ltd.
Frontage Labs
Xinbo
cas-test
Kerbio

Please note: The report will take approximately 2 business days to prepare and deliver. Show more